Table Info

Table 2.

PROs and limitations of TM for asthma patients

PROs	Limitations
Improved access to care	Requirement to specific equipment and to TM programs
Faster specialist input	Requirement to specific equipment and to TM programs
Reduced costs	Long-term efficacy unknown
Enhanced asthma management	Long-term efficacy unknown
Evaluation of clinical parameters in everyday setting	Lack of integration between specific TM programs and electronic health records
Reduced risk of exposure to infectious disease
Reduced carbon footprint	Higher age
Enhanced involvement in personal healthcare management	Increased paperwork requirement

TM: telemedicine. Data from [1–4, 24, 25]

Declarations

Author contributions

AGL and OCB: Conceptualization, Investigation, Visualization, Writing—original draft, Writing—review & editing. SDG: Conceptualization, Validation, Visualization, Writing—review & editing, Supervision. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Lin CH, Cerrone DA. Shifts in Asthma Evaluation and Management During COVID-19. Curr Treat Options Allergy. 2022;9:42–51. [DOI] [PubMed] [PMC]

Chipps B, Zeiger RS, Beuther DA, Reibman J, Wise RA, McCann W, et al. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control. Ann Allergy Asthma Immunol. 2023;131:436–43.e1. [DOI] [PubMed]

Davies B, Kenia P, Nagakumar P, Gupta A. Paediatric and adolescent asthma: A narrative review of telemedicine and emerging technologies for the post-COVID-19 era. Clin Exp Allergy. 2021;51:393–401. [DOI] [PubMed] [PMC]

Gilkey MB, Kong WY, Kennedy KL, Heisler-MacKinnon J, Faugno E, Gwinn B, et al. Leveraging Telemedicine to Reduce the Financial Burden of Asthma Care. J Allergy Clin Immunol Pract. 2022;10:2536–42. [DOI] [PubMed]

Hall K, Kafashzadeh D, Chen L, Dudovitz R, Ross MK. Trends in telemedicine visits among pediatric asthma patients during COVID-19. J Allergy Clin Immunol Glob. 2024;3:100239. [DOI] [PubMed] [PMC]

Hare N, Bansal P, Bajowala SS, Abramson SL, Chervinskiy S, Corriel R, et al. Work Group Report: COVID-19: Unmasking Telemedicine. J Allergy Clin Immunol Pract. 2020;8:2461–73.e3. [DOI] [PubMed] [PMC]

Raidou VS, Andreadou S, Christakou A, Kortianou EA. Digital Health Care in Chronic Respiratory Diseases during and beyond the COVID-19 pandemic. A Critical Review. Med Res Arch. 2023;11:3887. [DOI]

Smolinska S, Popescu F, Izquierdo E, Antolín-Amérigo D, Price OJ, Alvarez-Perea A, et al. Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper. Allergy. 2024;79:777–92. [DOI] [PubMed]

Alvarez-Perea A, Dimov V, Popescu F, Zubeldia JM. The applications of eHealth technologies in the management of asthma and allergic diseases. Clin Transl Allergy. 2021;11:e12061. [DOI] [PubMed] [PMC]

10.

Alvarez-Perea A, Sánchez-García S, Cano RM, Antolín-Amérigo D, Tsilochristou O, Stukus DR. Impact Of “eHealth” in Allergic Diseases and Allergic Patients. J Investig Allergol Clin Immunol. 2019;29:94–102. [DOI] [PubMed]

11.

Castner J, Mammen MJ, Jungquist CR, Licata O, Pender JJ, Wilding GE, et al. Validation of fitness tracker for sleep measures in women with asthma. J Asthma. 2019;56:719–30. [DOI] [PubMed] [PMC]

12.

Liu G, Guo Y, Zhu Q, Huang B, Wang L. Estimation of respiration rate from three-dimensional acceleration data based on body sensor network. Telemed J E Health. 2011;17:705–11. [DOI] [PubMed] [PMC]

13.

Greiwe J, Nyenhuis SM. Wearable Technology and How This Can Be Implemented into Clinical Practice. Curr Allergy Asthma Rep. 2020;20:36. [DOI] [PubMed] [PMC]

14.

Mosnaim G, Safioti G, Brown R, DePietro M, Szefler SJ, Lang DM, et al. Digital Health Technology in Asthma: A Comprehensive Scoping Review. J Allergy Clin Immunol Pract. 2021;9:2377–98. [DOI] [PubMed]

15.

Merchant RK, Inamdar R, Quade RC. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2016;4:455–63. [DOI] [PubMed]

16.

Bocian IY, Chin AR, Rodriguez A, Collins W, Sindher SB, Chinthrajah RS. Asthma management in the digital age. Front Allergy. 2024;5:1451768. [DOI] [PubMed] [PMC]

17.

Adhikari A, Hetherington A, Sur S. mmFlow: Facilitating At-Home Spirometry with 5G Smart Devices. In: 2021 18th Annual IEEE International Conference on Sensing, Communication, and Networking (SECON); 2021 6–9; Rome, Italy. IEEE. 2021. pp. 1–9. [DOI]

18.

Kouri A, Gupta S. Mobile health (mHealth) for asthma. CHEST Pulm. 2023;1:100002. [DOI]

19.

Murphy J, McSharry J, Hynes L, Molloy GJ. A Smartphone App to Support Adherence to Inhaled Corticosteroids in Young Adults With Asthma: Multi-Methods Feasibility Study. JMIR Form Res. 2021;5:e28784. [DOI] [PubMed] [PMC]

20.

Sousa-Pinto B, Eklund P, Pfaar O, Klimek L, Zuberbier T, Czarlewski W, et al. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021;11:e12062. [DOI] [PubMed] [PMC]

21.

Sapouna V, Kitixis P, Petrou E, Michailidou T, Dalamarinis P, Kortianou E. Mobile health applications designed for self-management of chronic pulmonary diseases in children and adolescents: a systematic mapping review. J Bras Pneumol. 2023;49:e20230201. [DOI] [PubMed] [PMC]

22.

Shenoy N, Nazeran H. A PDA-based Network for Telemonitoring Asthma Triggering Gases in the El Paso School Districts of the US - Mexico Border Region. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:5186–9. [DOI] [PubMed]

23.

Mosnaim GS, Greiwe J, Jariwala SP, Pleasants R, Merchant R. Digital Inhalers and Remote Patient Monitoring for Asthma. J Allergy Clin Immunol Pract. 2022;10:2525–33. [DOI] [PubMed]

24.

Portnoy JM, Waller M, De Lurgio S, Dinakar C. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol. 2016;117:241–5. [DOI] [PubMed]

25.

Mammen JR, Java JJ, Halterman J, Berliant MN, Crowley A, Frey SM, et al. Development and preliminary results of an Electronic Medical Record (EMR)-integrated smartphone telemedicine program to deliver asthma care remotely. J Telemed Telecare. 2021;27:217–30. [DOI] [PubMed]

26.

Huang C, Izmailova ES, Jackson N, Ellis R, Bhatia G, Ruddy M, et al. Remote FEV1 Monitoring in Asthma Patients: A Pilot Study. Clin Transl Sci. 2021;14:529–35. [DOI] [PubMed] [PMC]

27.

Reid D, Mehta J, Anis K, Mehta S. Impact of Remote Patient Monitoring Platform on Patients With Moderate to Severe Persistent Asthma: Observational Study. JMIR Form Res. 2023;7:e51065. [DOI] [PubMed] [PMC]

28.

Halterman JS, Fagnano M, Tremblay P, Butz A, Perry TT, Wang H. Effect of the Telemedicine Enhanced Asthma Management Through the Emergency Department (TEAM-ED) Program on Asthma Morbidity: A Randomized Controlled Trial. J Pediatr. 2024;266:113867. [DOI] [PubMed]

29.

Drake C, Lian T, Cameron B, Medynskaya K, Bosworth HB, Shah K. Understanding Telemedicine’s “New Normal”: Variations in Telemedicine Use by Specialty Line and Patient Demographics. Telemed J E Health. 2022;28:51–9. [DOI] [PubMed] [PMC]